National Chemical Laboratory has 7% staff and relatives Seropositive at Pune

▴ National Chemical Laboratory has 7% staff and relatives Seropositive at Pune
In an internal Covid audit under Phenome India revealed the stats

A seropositive rate of 7 per cent was revealed in serological tests conducted by the CSIR- National Chemical Laboratory (NCL) among its staff and family members.
A serological test reveals if a person has developed antibodies to the coronavirus, a positive result indicating that he/she has already been exposed to the virus.

"Among 339 participants, 18 men and six women were found to be seropositive, which accounts for about 7 per cent of the total sample. These comprise 19 students, 3 contract staff and 2 family members," an official said.

The study was part of a project led by the Council of Scientific and Industrial Research (CSIR)-Institute of Genomics and Integrative Biology. This initiative was a part of the PAN India project named ‘Phenome India initiated by Council of Scientific and Industrial Research (CSIR) and led by Delhi-based CSIR- Institute of Genomics and Integrative Biology and Dr. Shantanu Sengupta from CSIR-IGIB is coordinating. This research study involves testing of antibodies against SARS-CoV-2 in the people working in the CSIR labs and their family members under "Phenome India - A long-term longitudinal observational cohort study of health outcomes." The CSIR-NCL and CSIR-URDIP represent the western region.

The CSIR-NCL team comprises scientists from the Biochemical Sciences Division and doctors from the Medical Centre. The serological testing at The CSIR-NCL started on 12 September 2020 at NCL Medical Center and concluded on 24th September. The blood samples along with the health data will be sent to CSIR-IGIB for serological analysis. Blood samples are being collected from those who are willing to participate. The test is voluntary and open to all CSIR staff, including pensioners (up to the age of 70 yr), students, contractual staff and their families (aged 18 yrs and above). 

Tags : #PhenomeIndia #NationalChemicalLaboratoryPune #CSIR-NCL #LatestPuneCovidNewsUpdateSep26 #LatestSeropostiveNewsSep26 #IndiaCovidNewsUpdateSep26

About the Author


Team Medicircle

Related Stories

01 Feb

Novavax applies for FDA emergency use authorization of its coronavirus vaccine

Latest Corporate News; Pharma Jan1st/2022

View
30 Dec

Novavax and SK bioscience Expand Manufacturing Agreement

Latest pharma news update

View
06 Jul

Spero Therapeutics entered into licensing agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories

Latest Pharma News Update

View
26 Jun

Country soon to get world’s first DNA-plasmid vaccine by Zydus Cadilla: Chairman COVID-19 NTAGI

Zydus Cadila vaccine to be available by September

View
24 Feb

Pfizer and Moderns pledges US Govt for 240 million doses of vaccine by March end

J&J also applied for emergency application

View
09 Feb

Afghanistan receives 500,000 doses of AstraZeneca’s COVID-19 vaccine from India

Afghanistan has had 55,335 COVID-19 cases and 2,410 deaths from the disease, according to the health ministry.

View
08 Feb

Today Bangladesh starts nationwide COVID-19 vaccination program

Bangladesh rolls out nationwide vaccination program with AstraZeneca-Oxford vaccine

View
15 Jan

ViiV Healthcare receives EU Marketing Authorisation for Tivicay, a treatment for children living with HIV in Europe

Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV

View
29 Dec

Novavax coronavirus vaccine becomes fifth to begin Phase 3 trials in United States

Novavax is also currently conducting a Phase 3 clinical study in the United Kingdom, a Phase 2b trial in South Africa and a Phase 1/2 continuation in the US and Australia

View
30 Nov

Novavax delays U.S. COVID-19 vaccine trial again, now sees start in the coming weeks

Vaccine maker Novavax Inc said on Monday it has pushed back the start of a U.S.-based, late-stage trial for its experimental COVID-19 vaccine and now expects it to begin in the coming weeks instead of November.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025